Project description
Integrated solutions for heart failure patients
In Europe, 15 million people live with heart failure and many of them with multimorbidity. The care model in place for these patients implies one specialist for each comorbidity. The medication becomes complex to manage and risky if not handled properly. Severe episodes imply costly hospitalisation and decline in quality of life, penalising both the patient and the health care system. The EU-funded TIQUE project will make extensive use of cutting-edge technologies to reduce avoidable hospitalisations and preserve the health status of the patient. Smart devices at home, artificial intelligence to anticipate and prevent crisis, and implementation of new care pathways are main components of the value-based service to be designed.
Objective
Heart failure (HF) is the leading cause of hospitalisation in people over the age of 65 and carries a high cost to healthcare systems. It also exerts a significant economic toll on patients, their families and society in general; more the 15 million people are living with HF in Europe. Despite the considerable burden to human life and healthcare costs there has been scarce innovation in treatments in the past several decades: HF occurs mainly in the older population that may mistake symptoms as being the natural result of ageing and therefore not recognized until the condition has reached a severe stage. Poor management of HF increases the risk and frequency of acute episodes resulting in hospitalizations, poor quality of life and high burden on healthcare systems. The recent COVID-19 pandemic has evidenced that fearing to be infected, cardiovascular patients delay care.
A state-of-the-art search indicated that that integrated care is crucial for improving the health care services, wellbeing and engagement through shared decision-making, education and support to self-management. Existing solutions are local and there is no common effective solution available in the market. Public procurers cannot go to open tender to deploy effective solutions for advanced heart failure. The TIQUE Consortium recognised Pre-Commercial Procurement (PCP) as the only way to stimulate the market to find a solution to the common problem. TIQUE will bring to the market new integrated care solutions implementing a predictive, preventive, personalized and participatory model of health care services for patients with heart failure.
TIQUE will stimulate European industry to become a global leader in this innovative field. Use of PCP is of particular interest to the consortium members some of them are familiar with PCP and PPI and in using them strategically while others are new adopters. The consortium will proactively share PCP knowledge with the PiPPI and EURIPHI communities of practice.
Fields of science
Programme(s)
Funding Scheme
PCP - Pre-Commercial ProcurementCoordinator
08025 Barcelona
Spain